|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.3 EUR | +1.42% |
|
-1.79% | +98.61% |
| 05-15 | Medincell: share price falls after disappointing clinical study | CF |
| 05-15 | Transcript : MedinCell S.A. - Special Call |
MedinCell S.A. reported earnings results for the half year ended September 30, 2022. For the half year, the company reported revenue was EUR 7.71 million compared to EUR 4.08 million a year ago. Net loss was EUR 13.75 million compared to EUR 11.76 million a year ago.
Basic loss per share from continuing operations was EUR 0.55 compared to EUR 0.47 a year ago. Diluted loss per share from continuing operations was EUR 0.55 compared to EUR 0.47 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +98.61% | 445M | |
| +37.74% | 723B | |
| +32.22% | 598B | |
| -2.07% | 364B | |
| +20.25% | 331B | |
| +2.99% | 288B | |
| +16.60% | 244B | |
| +9.77% | 210B | |
| -5.15% | 208B | |
| +7.43% | 169B |
MEDINCELL S.A. 
